The global biological safety cabinet market size was valued at USD 211.04 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.62% from 2024 to 2030. Biological safety cabinets (BSCs) are used primarily to contain infectious pathogens and hazardous chemicals while working on research. These cabinets include basic systems like HEPA filters, Laminar Airflow, workstations, ventilated cabinets, and exhausts. These safety cabinets must meet international standards and must be ISO certified.
Key factors driving the market's growth include increased incidence of chronic diseases, rising geriatric population, and demand for wireless and portable systems. In addition, extensive R&D by many pharmaceutical and biopharmaceutical firms and favorable regulations are expected to drive the market. It requires proper infrastructure and equipment facilities to conduct scientific research; therefore, the ventilated biological safety cabinets will play a crucial role in registering momentous growth.
While working on perilous pathogenic organisms or volatile chemicals, the researcher's and the environment's safety and protection are very important. BSC contains components like HEPA filters, ultraviolet lamps, laminar flow cabinets, etc. that protect by creating a sterile environment and workstation.
The increasing prevalence of chronic diseases, such as cancer, respiratory diseases, and Alzheimer's, has resulted in a rise in research. For instance, according to the American Cancer Society, Inc., in 2023, around 2.0 million new cancer cases and 609,820 cancer deaths are estimated to occur in the U.S. Hence, the need for advanced safety equipment, including BSC, is expected to increase. On the other hand, the high costs of this equipment and the introduction of more efficient and reliable alternatives may limit the market's growth.
The market growth stage is high, and the market growth is accelerating. The BSC market is characterized by a high degree of innovation due to the introduction of innovative features in biological safety cabinets, such as HEPA filters, UV sterilization, and automatic doors. Moreover, the industrial segment is investing heavily in research and development to drive innovation and improve these cabinets' airflow patterns, filtration systems, and ergonomic designs to ensure maximum safety and user comfort.
The BSC market is also characterized by the leading players' high level of merger and acquisition (M&A) activity. This is due to several factors, including the desire to gain access to new BSC technologies and talent, the need to consolidate in a rapidly growing market, and its usage in research and development.
The BSC market is significantly influenced by regulations, which drive the adoption of these cabinets. Strict guidelines from regulatory bodies such as the FDA, CDC, and EMA mandate the use of biological safety cabinets to maintain the required levels of sterility and ensure laboratory safety. It has led to a growing emphasis on laboratory safety regulations and adopting biosafety measures in research and diagnostic laboratories.
The product and service expansion in the BSC market is high due to several factors, such as increasing demand for biological safety cabinets in various industries, including pharmaceuticals, biotechnology, and research laboratories. The rising concern about the global spread of pandemics has also increased demand for BSC.
In the BSC market, regional expansion involves BSC companies strategically extending their activities beyond current geographic locations. Hence, the market players undertake various business initiatives, such as partnerships, geographical expansion, and collaboration, to gain a regional customer base.
The Class II segment accounted for the highest share of more than 41.7% in 2023. The Class II segment is further bifurcated into Type A and Type B. The growth is attributed as these systems provide complete protection and are widely used in basic research activities. Hence, several companies invest in launching and advancing BSCs. For instance, in November 2023, Esco Micro Pte. Ltd. announced the launch of the Innovative Labculture Plus G4 Class II Biosafety Cabinet.
The Class I segment is anticipated to witness significant growth during the forecast period. The growth is because class I BSCs are the first cabinets recognized as BSCs and provide personnel and environmental protection. Furthermore, these are also the most widely used BSCs globally due to the design simplicity of these cabinets. These cabinets are mainly used for activities involving exposure to radionuclides and volatile toxic chemicals.
The pharmaceutical & biopharmaceutical companies segment led the market in 2023. The growth is attributed to the increased number of approved pharmaceutical products, which is also anticipated to fuel the market demand. For instance, in 2023, the FDA approved 55 new drugs. Furthermore, some formulations with cytotoxic or Active Pharmaceutical Ingredient (API) powders may pose health risks for the personnel during the manufacturing & development process and, thus, demand the use of safety cabinets to protect the product and personnel from exposure to airborne particulate or biological, chemical substances, which is expected to facilitate market growth.
The diagnostics & testing laboratories segment is also anticipated to witness a substantial upsurge in the BSC market. These pathological and bioprocessing processes require the maintenance of a sterile environment and the use of protective equipment to prevent contaminations, false readings, and exposure to biohazards since the majority of the pathological and bioprocessing services involve the handling of hazardous chemicals & substances, thus facilitating the demand for biosafety cabinets. For instance, in October 2023, the WHO released the Essential Diagnostics List (EDL), a register of in vitro diagnostics (IVD) based on evidence supporting countries in making national diagnostics decisions.
North America dominated the market, accounting for a 32.21% share in 2023. The growth in the BSC market is attributed to the local presence of major players involved in the intensive investigation of new drug candidates against various diseases. Furthermore, several initiatives in biotechnology in the U.S. contributed to the region's strong position in the market. For instance, in March 2023, the U.S. government announced priorities and goals to advance American biomanufacturing and biotechnology. It included a plan for innovating and strengthening biosafety and biosecurity for the bioeconomy, expanding education and training opportunities for the biomanufacturing and biotechnology workforce, a strategy for expanding national biomanufacturing facilities, and more.
Asia Pacific is anticipated to witness significant growth in the biological safety cabinet market. Ongoing studies in drug discovery, private-public collaborations, and government initiatives are other factors likely to drive the growth of the Asian biological safety cabinets market. For instance, in December 2023, WHO announced that it collaborated with the Ministry of Health and Population (MoHP) and the Country Office for Nepal for training on basic certification practices of BSC to promote skilled professionals of in-country certifiers.
Some of the key players operating in the market include Thermo Fisher Scientific, Inc., and Germfree
Thermo Fisher Scientific, Inc. operates in four business segments: Laboratory Products & Biopharma Services, Life Sciences Solutions, Specialty Diagnostics, and Analytical Instruments. The company serves pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, government agencies and research institutes, universities, and many other organizations.
Germfree offers end-to-end solutions for the next-generation biocontainment, pharmacy, and biopharma cleanroom technologies. The company works on projects in its U.S. manufacturing plant, where the engineering teams, advanced technology, and skilled professionals are located.
Haier Biomedical (Qingdao Biomedical Co., Ltd.) and Air Science USA LLC are some of the emerging market participants in the BSC market.
Haier Biomedical (Qingdao Biomedical Co., Ltd.) specializes in the manufacturing, research & development, and sales of low-temperature storage equipment for biomedical samples. The company offers a digital scenario solution provider using the Internet of Things (IoT) in medical innovation and life science.
Air Science manufactures a series of ductless workstations, ductless fume hoods, custom enclosures, and laboratory filtration products. The company offers products and manufacturing processes to minimize the environmental effects on the community. It supports efforts to comply with Leadership in Energy and Environmental Design (LEED) and other recommended laboratory and facility management approaches.
The following are the leading companies in the biological safety cabinet market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these biological safety cabinet companies are analyzed to map the supply network.
In November 2023, Esco Micro Pte. Ltd. launched a Class II type BSC and conducted a biosafety and chemical safety awareness conference in ARABLAB 2023.
In April 2023, AZBIL TELSTAR, S.L.U. announced the company's expansion in Lainate, Italy. The expansion will help the company to strengthen its presence in Italy's BSC market.
Market size value in 2024
USD 226.79 million
Revenue forecast in 2030
USD 352.41 million
CAGR of 7.62% from 2024 to 2030
Base year for estimation
2018 - 2022
2024 - 2030
Revenue in USD billion and CAGR from 2024 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; UAE; South Africa; Kuwait
Key companies profiled
Thermo Fisher Scientific, Inc.; Labconco Corp.; NuAire, Inc.; The Baker Company, Inc.; AZBIL TELSTAR, S.L.U.; Jinan Biobase Biotech Co. Ltd.; Germfree Laboratories, Inc.; Air Science, Inc.; Haier Biomedical (Qingdao Biomedical Co., Ltd.); Cruma S.A.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global biological safety cabinet market report based on product, end-use, and region:
Product Outlook (Revenue, USD Billion, 2018 - 2030)
Class II Type A
Class II Type B
End-Use Outlook (Revenue, USD Billion, 2018 - 2030)
Pharmaceutical & Biopharmaceutical Companies
Diagnostics & Testing Laboratories
Academic & Research Organizations
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
Middle East and Africa (MEA)
b. The global biological safety cabinet market size was estimated at USD 211.04 million in 2023 and is expected to reach USD 226.79 million in 2024.
b. The global biological safety cabinet market is expected to grow at a compound annual growth rate of 7.62% from 2024 to 2030 to reach USD 352.41 million by 2030.
b. North America dominated the biological safety cabinet market with a share of 32.21% in 2023. This is attributable to rising incidence of chronic diseases, well developed & increasing R&D activities, presence of large number of multinational pharma & biopharmaceutical companies.
b. Some key players operating in the biological safety cabinet market include Thermo Fisher Scientific, Inc, Labconco Corp., NuAire, Inc., The Baker Company, Inc., AZBIL TELSTAR, S.L.U., Jinan Biobase Biotech Co. Ltd., Germfree Laboratories, Inc., Air Science USA LLC, Haier Biomedical (Qingdao Biomedical Co., Ltd.), Cruma S.A.
b. Key factors that are driving the market growth include rapid growth in the number of biologics, increasing R&D activities, and the increasing need to safeguard products, agents, personnel, and environment from biohazard exposure and cross-contamination during procedures
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."